HTGPCR Family Genes in Cancer
Author Information
Author(s): Liu Simeng, He Mingang, Sun Hefen, Wu Yi, Jin Wei, Roue Gael
Primary Institution: Fudan University Shanghai Cancer Center
Hypothesis
The study aims to determine the potential role and distinct prognostic significance of HTGPCRs as biomarkers in cancer diagnosis and therapy.
Conclusion
HTGPCRs hold considerable promise as prognostic indicators and offer insights into therapeutic targets for malignancy.
Supporting Evidence
- HTGPCR gene expression was correlated with prognosis in many cancers.
- HTR1D/2C were associated with poorer overall survival for head and neck squamous cell carcinoma.
- HTGPCR expression correlated significantly with stemness scores and immune scores in pan-cancer patients.
Takeaway
This study looks at a group of genes that help cancer grow and how they can be used to predict how well patients will do and how they might respond to treatment.
Methodology
The study utilized TCGA cancer datasets to explore the relationship between HTGPCRs and 33 different types of cancer, analyzing gene expression, survival rates, and immune infiltration.
Potential Biases
Some HTGPCR alterations may overlap with non-cancerous inflammatory or immune conditions.
Limitations
The study relies on bioinformatic analysis of publicly available databases, which may not capture all relevant biological nuances.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website